However, in mice adoptively transferred with PBMCs, LSKAA-OE PDXs had a greater reduction in tumor growth compared with control or LCOR-OE PDXs (Figure 7E), along with a higher percentage of immune infiltration, measured as the fraction of CD45+CD3+ immune cells (Figure 7F). The gene discussed is PTPRC; the disease is neoplasm.